Value in Cancer Care Summit 2023

Heather Cheng, MD, PhD is an Associate Professor in the Division of Hematology and Oncology, Department of Medicine at the University of Washington and an Associate Professor in the Clinical Research Division and the Director of Prostate Cancer Genetics Clinic at Fred Hutchinson Cancer Center. Dr. Cheng is a medical oncologist whose research and clinical practice centers around heritable (germline) and tumor-specific (somatic) genetics of prostate cancer. She conducts clinical trials relevant to men with germline mutations in genes such as BRCA2 and others implicated in prostate cancer risk and aggressiveness, which also serve as biomarkers for precision therapy. 

Scott Ramsey, MD, PhD is a Professor in the Cancer Prevention Program, Public Health Sciences Division at the Fred Hutchinson Cancer Center, where he directs the Hutchinson Institute for Cancer Outcomes Research. Dr. Ramsey is a Professor in the Schools of Medicine and Pharmacy at the University of Washington. Trained in Medicine and Economics, Dr. Ramsey’s research focuses on economic evaluations in cancer. Dr. Ramsey is co-chair of the Cancer Delivery Committee at SWOG, past President of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) and has served on the Institute of Medicine Cancer Policy Forum.

Veena Shankaran, MD is a GI medical oncologist and health services researcher. She is a Joint Professor in the Cancer Prevention Research program, Public Health Sciences Division at the Fred Hutchinson Cancer Center, where she serves as Co-Director of the Hutchinson Institute for Cancer Outcomes Research, a multidisciplinary team devoted to clinical and economic evaluations of new and existing cancer prevention, screening, and treatment technologies. In addition, she has a busy clinical practice at the Seattle Cancer Care Alliance and serves as the local PI on a number of clinical trials in esophageal and gastric cancer. Dr. Shankaran is an Associate Professor in the School of Medicine at the University of Washington.

Katie Treend, MPH is the lead program staff for the Washington State Cancer Control Program. Katie has worked in this role for more than 6 years and coordinates a variety of cancer prevention and survivorship initiatives. Katie works directly with community partners and stakeholders on projects related to HPV vaccination, tobacco cessation, colorectal cancer screening, and more. Katie also co-leads the WA HPV Free Task Force, the Colorectal Cancer Task Force, the Cancer Survivorship Provider Network and is currently relaunching a state-wide Cancer Coalition guided by a newly drafted 5-year Cancer Plan. Katie received her undergraduate degree Psychology from Western Washington University, and her Master’s in Public Health from the University of Washington.

Robin Yabroff, PhD, MBA is a Scientific Vice President, Health Services Research at the American Cancer Society. Dr. Yabroff leads a team of scientists whose research focuses on the financial hardship and economic burden of cancer, health insurance coverage and benefit design, and factors associated with the quality and value of cancer care. Dr. Yabroff holds adjunct faculty positions in the Department of Medicine at Johns Hopkins University and in the Department of Health Policy and Management at Emory University’s Rollins School of Public Health. She serves as Deputy Editor, Journal of the National Cancer Institute and on the Editorial Boards of the Journal of Cancer Survivorship and the JCO Oncology Practice.